Title:
Altoida begins multicentre Alzheimer’s study with AI-based device
Published:
NS Medical Devices, 19 October 2021
From the article:
To validate its device’s capability to detect early neurocognitive impairments, Altoida will assess its software and digital biomarker data alongside a breadth of clinical data.
Altoida has collaborated with Eisai and Ionian University to begin a five-year Alzheimer’s disease study with its artificial intelligence (AI)-based software device.